Biography

Dr. Andrea G. Hohmann is a Linda & Jack Gill Chair for Neuroscience and a Distinguished Professor of Psychological and Brain Sciences at Indiana University Bloomington. She leads a nationally recognized research program focused on uncovering the neurochemical mechanisms of pain modulation and endocannabinoid signaling, aiming to identify novel therapeutic strategies that suppress pain without addiction or other adverse side effects.
 
Dr. Hohmann received her Sc.B., Sc.M., and Ph.D. from Brown University and completed postdoctoral training in functional neuroanatomy and pain mechanisms at the National Institute of Mental Health and the National Institute of Dental and Craniofacial Research. She joined Indiana University in 2010 after faculty appointments at the University of Georgia.

Her laboratory has been at the forefront of endocannabinoid research, mapping cannabinoid receptor systems in sensory pathways and demonstrating how both endogenous cannabinoids and cannabinoid receptor mechanisms can suppress pathological pain states in rodent models. This work has identified novel analgesic targets such as monoacylglycerol lipase and validated CB2 receptor–mediated mechanisms that reduce neuropathic and inflammatory nociception.

Dr. Hohmann’s contributions are widely published in leading neuroscience and pharmacology journals, including studies on cannabinoid receptor modulation, mechanisms of chemotherapy-induced neuropathy, and protein-protein interactions that influence pain and morphine tolerance.

In recognition of her sustained impact on cannabinoid science, she received the 2025 Raphael Mechoulam Award from the International Cannabinoid Research Society — one of the field’s highest honors.

Publications

View additional publications